The Persistent Challenge of Febrile Illnesses in South Asian Children

Febrile illnesses, characterized by elevated body temperature often due to infections, represent a significant health burden for children in low-resource settings across South and Southeast Asia. In India, where rural healthcare infrastructure faces immense pressure, these conditions frequently lead to life-threatening complications like sepsis if not managed promptly. Despite progress in reducing under-five mortality rates from 92 deaths per 1,000 live births in 2000 to around 32 in 2024, infectious diseases such as pneumonia and sepsis continue to claim thousands of young lives annually. Pneumonia alone accounts for a substantial portion of these deaths, underscoring the need for accurate triage tools at the community level to identify children requiring urgent hospital referral.

Rural India, home to over 65% of the population, relies heavily on frontline health workers using protocols like the Integrated Management of Neonatal and Childhood Illness (IMNCI), adapted from World Health Organization (WHO) guidelines. These protocols emphasize general danger signs such as inability to drink or breastfeed, persistent vomiting, convulsions, or lethargy. However, real-world application reveals gaps, with many high-risk cases overlooked, leading to delayed interventions and overburdened tertiary facilities.

Shortcomings of Existing WHO Danger Signs

The WHO danger signs, integral to IMNCI in India, aim to flag severe illness but suffer from low sensitivity. A landmark study highlights that these criteria miss nearly 45% of children who progress to death or require organ support within two days of presentation. In Indian contexts, where access to higher care can take hours or days due to geographic barriers, this limitation exacerbates mortality risks. Community health centers often see high volumes of febrile cases, resulting in referral rates around 17%, many unnecessary, straining limited hospital beds and resources.

Local studies in rural India corroborate these issues, showing that fever without localizing signs frequently masks serious bacterial infections, including sepsis. Over-reliance on subjective clinical judgment by auxiliary nurse midwives (ANMs) and anganwadi workers leads to both under- and over-referral, impacting care equity.

The Spot Sepsis Study: A Game-Changer from MORU

The Mahidol Oxford Tropical Medicine Research Unit (MORU), in collaboration with Médecins Sans Frontières (MSF), launched the Spot Sepsis study to address these gaps. Published in Nature Medicine on April 29, 2026, this prospective cohort research is the largest of its kind, analyzing data from 3,405 children aged 1-59 months with community-acquired acute febrile illnesses across seven rural hospitals in Bangladesh, Cambodia, Indonesia, Laos, and Vietnam. Led by Dr. Arjun Chandna, with principal investigators Professor Yoel Lubell and Dr. Sakib Burza, the study developed and validated clinical prediction models tailored for low-resource primary care.

While sites were in neighboring countries, the findings hold direct relevance for India, sharing similar epidemiological profiles, climate-driven infection patterns, and healthcare challenges in rural South Asia.

Methodology: Rigorous Data Collection and Model Development

From 2020 to 2022, researchers screened over 11,000 children, enrolling those with fever for detailed assessment. Clinical parameters—including vital signs, respiratory rate, and WHO danger signs—were combined with objective measures like pulse oximetry (measuring blood oxygen saturation, SpO2) and serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), a host biomarker indicating immune activation in sepsis.

Models were derived using backward stepwise logistic regression on data from six sites, externally validated on Cambodian data. The primary outcome was severe disease: death or need for organ support (e.g., oxygen, fluids, ventilation) within 48 hours. A traffic-light triage system was proposed: low-risk (<0.5% probability: discharge; intermediate 0.5-2%: monitor; high >2%: refer).

Breakthrough Findings: Enhanced Sensitivity and Specificity

The clinical signs-only model achieved 74.7% sensitivity (95% CI: 59.4-88.1%) and 99.1% specificity (95% CI: 97.7-99.7%), outperforming WHO criteria (55.5% sensitivity, 82.6% specificity). Adding pulse oximetry boosted sensitivity to 88.9% (95% CI: 76.7-97.8%), identifying 89% of the 133 severe cases (3.9% of cohort). The sTREM-1 model reached 89.2% sensitivity (95% CI: 76.9-97.5%).

• WHO missed 44.5% high-risk children; new models captured nearly 90%.
• Referral rates projected to fall from 17% to under 5%, freeing resources.
• Positive likelihood ratio for pulse oximetry model: 150.7, enabling confident rule-in.

Dr. Chandna noted, "These tools could identify more sick children while reducing unnecessary referrals."

Photo by Ilja Nedilko on Unsplash

Pulse Oximetry: A Simple, Scalable Solution

Pulse oximetry, a non-invasive device clipping onto a finger to measure SpO2, emerges as the most practical enhancement. Thresholds like SpO2 <92% flag hypoxia, common in pneumonia and sepsis. Prior Indian studies affirm its cost-effectiveness for childhood pneumonia triage, potentially averting deaths at low expense. In rural Uttar Pradesh and Bihar, integrating it into IMNCI could empower ASHA workers without needing labs.

At $26.28 per life-year saved, it's highly economical, aligning with India's push for affordable diagnostics under Ayushman Bharat.

sTREM-1 Biomarker: Precision for High-Stakes Cases

sTREM-1, detectable via rapid blood tests, signals myeloid cell activation in bacterial infections. Though requiring point-of-care labs, its 89% sensitivity positions it for semi-urban PHCs in India. Emerging sepsis biomarker research in Indian children supports its prognostic value, though scalability needs validation. For full study details, see the Nature Medicine publication.

Cost-Effectiveness: Saving Lives and Resources

Professor Lubell's analysis, modeled in Bangladesh (analogous to rural India), shows all models cost-saving versus WHO. Pulse oximetry's ICER ($26/LYS) and sTREM-1 ($196/LYS) beat thresholds for low-income settings. Scaling could prevent thousands of deaths regionally, with India's 1.4 lakh annual pneumonia deaths highlighting urgency.

Relevance to India's Rural Healthcare Landscape

India's IMNCI framework mirrors WHO protocols, making integration feasible. With 25% of global under-five deaths in South Asia, tools like these could bolster ASHA and ANM capabilities. Pilot programs in high-burden states like Bihar and Uttar Pradesh, incorporating pulse oximeters (already distributed under NHM), could reduce sepsis mortality. Challenges include training and device maintenance, but evidence supports viability.

MSF's Dr. Burza emphasized utility in conflict/remote areas, akin to India's tribal belts.

Implementation Challenges and Strategies

• Training: Capacity building for 1 million ASHAs via NHM modules.
• Supply Chain: Ensure pulse oximeters via Jan Aushadhi; sTREM-1 for CHCs.
• Equity: Target poorest quintiles, where pneumonia deaths cluster.
• Monitoring: Digital HMIS integration for real-time outcomes.

Stakeholder buy-in from MoHFW and ICMR is crucial for trials.

Photo by Mad Knoxx Deluxe on Unsplash

Future Outlook: Trials and Policy Integration

Community trials in India are next, potentially adapting models culturally. Broader biomarker research, including AI-driven scores, promises further gains. For more, visit MORU's announcement. Global adoption could halve sepsis deaths, aligning with SDG 3.2.